V. Yu. Shanin

V. Yu. Shanin

Auto-generated profile, based on publicly available information

V. Yu. Shanin

Medical University “Reaviz

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2023 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
ESE. V. Shanina
E. V. Shanina
FBF. Breker
F. Breker
NLN. A. Lysov
N. A. Lysov
VSV. Yu. Shanin
V. Yu. Shanin
YPYu. V. Ponomareva
Yu. V. Ponomareva
ASA. A. Supil'NIkov
A. A. Supil'NIkov
The aim of the study was to evaluate the relationship between chemotherapy and autoimmune reactions in patients with metastatic colorectal cancer. Cancer and autoimmunity are known to be interrelated, but until now it has been unclear to what extent chemotherapy specifically contributes to autoimmune reactions. We studied immunoglobulin M (IgM) levels in response to the administration of various human tissues before and during adjuvant chemotherapy. Patients received seven cycles of chemotherapy with the FOLFIRI plus cetuximab regimen. IgM levels against the tested tissues increased already after the first cycle of chemotherapy and continued to increase during the second and third cycles. Autoimmune responses then began to decrease from the fourth to seventh cycles, but remained elevated from baseline for most of the study tissues. Our results suggest that chemotherapy can induce a wide range of autoimmune reactions. Monitoring self-reactive IgM responses during treatment may help prevent or alleviate side effects associated with autoimmunity.